AMGEN INC

Profile

Company Names

AMGEN INC

Addresses

ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA 91320

Phone Numbers

(805) 447-1000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$0.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2011-09-28 
$0.00 
$2,500,000,000.00 
$2,500,000,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MADHAVAN 
 
BALACHANDRAN 
EXECUTIVE OFFICER
AMGEN INC   |  CATALENT, INC.   |  ADRX, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  NUTCRACKER THERAPEUTICS, INC.
DAVID 
 
BALTIMORE 
DIRECTOR
IMMUNE DESIGN CORP.   |  REGULUS THERAPEUTICS INC.   |  AMGEN INC   |  NANOMEDIX INC.
DAVID 
W 
BEIER 
EXECUTIVE OFFICER
AMGEN INC
FRANK 
J 
BIONDI, JR. 
DIRECTOR
AMGEN INC
FRANK 
J. 
BIONDI, JR. 
DIRECTOR
SEAGATE TECHNOLOGY PLC   |  AMGEN INC
FABRIZIO 
 
BONANNI 
EXECUTIVE OFFICER
AMGEN INC   |  THERANOS INC   |  COG BIOPHARMA SERVICES, INC.   |  INCOG BIOPHARMA SERVICES, INC.
ROBERT 
A 
BRADWAY 
EXECUTIVE OFFICER, DIRECTOR
AMGEN INC
ROBERT 
A. 
BRADWAY 
EXECUTIVE OFFICER, DIRECTOR
AMGEN INC
VANCE 
 
COFFMAN 
DIRECTOR
AMGEN INC
VANCE 
D 
COFFMAN 
DIRECTOR
AMGEN INC
VANCE 
D. 
COFFMAN 
DIRECTOR
AMGEN INC
FRANCOIS 
 
DE CARBONNEL 
DIRECTOR
AMGEN INC
THOMAS 
 
DITTRICH 
EXECUTIVE OFFICER
AMGEN INC
THOMAS 
J.W. 
DITTRICH 
EXECUTIVE OFFICER
AMGEN INC
ROBERT 
A. 
ECKERT 
DIRECTOR
AMGEN INC
GREG 
C. 
GARLAND 
DIRECTOR
AMGEN INC
SEAN 
E. 
HARPER 
EXECUTIVE OFFICER
AMGEN INC
REBECCA 
 
HENDERSON 
DIRECTOR
AMGEN INC
REBECCA 
M. 
HENDERSON 
DIRECTOR
AMGEN INC
FRANK 
C 
HERRINGER 
DIRECTOR
AMGEN INC
FRANK 
C. 
HERRINGER 
DIRECTOR
AMGEN INC   |  CARDAX PHARMA, INC.   |  CARDAX, INC.
ANTHONY 
C. 
HOOPER 
EXECUTIVE OFFICER
AMGEN INC
TYLER 
 
JACKS 
DIRECTOR
AMGEN INC
MICHAEL 
A. 
KELLY 
EXECUTIVE OFFICER
AMGEN INC   |  AMICUS THERAPEUTICS, INC.
BRIAN 
M 
MCNAMEE 
EXECUTIVE OFFICER
AMGEN INC
BRIAN 
M. 
MCNAMEE 
EXECUTIVE OFFICER
AMGEN INC
DAVID 
W. 
MELINE 
EXECUTIVE OFFICER
AMGEN INC
GILBERT 
S 
OMENN 
DIRECTOR
AMGEN INC   |  GALECTIN THERAPEUTICS INC
GILBERT 
S. 
OMENN 
DIRECTOR
AMGEN INC   |  ESPERION THERAPEUTICS, INC.   |  MEDSYN BIOPHARMA LLC
CYNTHIA 
 
PATTON 
EXECUTIVE OFFICER
AMGEN INC
CYNTHIA 
M. 
PATTON 
EXECUTIVE OFFICER
AMGEN INC
JONATHAN 
 
PEACOCK 
EXECUTIVE OFFICER
AMGEN INC   |  BELLEROPHON THERAPEUTICS LLC   |  ARIX BIOSCIENCE PLC   |  BELLEROPHON THERAPEUTICS, INC.
JONATHAN 
M 
PEACOCK 
EXECUTIVE OFFICER
MICROMET, INC.   |  AMGEN INC
JUDITH 
C 
PELHAM 
DIRECTOR
AMGEN INC
JUDITH 
C. 
PELHAM 
DIRECTOR
AMGEN INC
DAVID 
 
PIACQUAD 
EXECUTIVE OFFICER
AMGEN INC
J 
PAUL 
REASON 
DIRECTOR
AMGEN INC
J. 
PAUL 
REASON 
DIRECTOR
AMGEN INC
ANNA 
S 
RICHO 
EXECUTIVE OFFICER
AMGEN INC
LEONARD 
D 
SCHAEFFER 
DIRECTOR
AMGEN INC
LEONARD 
D. 
SCHAEFFER 
DIRECTOR
AMGEN INC
DAVID 
J 
SCOTT 
EXECUTIVE OFFICER
MICROMET, INC.   |  AMGEN INC
DAVID 
J. 
SCOTT 
EXECUTIVE OFFICER
AMGEN INC
KEVIN 
W 
SHARER 
EXECUTIVE OFFICER, DIRECTOR
AMGEN INC
RONALD 
D 
SUGAR 
DIRECTOR
AMGEN INC
RONALD 
D. 
SUGAR 
DIRECTOR
AIR LEASE CORP   |  AMGEN INC
SCOTT 
A. 
TROSS 
EXECUTIVE OFFICER
AMGEN INC
STUART 
A. 
TROSS 
EXECUTIVE OFFICER
AMGEN INC
R. 
SANDERS 
WILLIAMS 
DIRECTOR
AMGEN INC   |  E-SCAPE BIO, INC.   |  ESCAPE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-01-23
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28 
2014-01-29
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28 
2013-02-04
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28 
2012-02-29
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GOLDMAN, SACHS + CO.
361
NONE
NONE
BARCLAYS CAPITAL INC.
19714
NONE
NONE
CITIGROUP GLOBAL MARKETS INC.
7059
NONE
NONE
BANC OF AMERICA SECURITIES LLC
26091
NONE
NONE
MORGAN STANLEY + CO. INCORPORATED
8209
NONE
NONE
DEUTSCHE BANK SECURITIES INC.
2525
NONE
NONE
BARCLAYS CAPITAL INC
19714